Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Silmitasertib sodium salt | 1309357-15-0 | 99.92% | C19H11ClN3NaO2 | 1 G
SDP

Supplier:  Medchemexpress LLC HY50855B1G

Encompass_Preferred

Silmitasertib sodium salt is an orally bioavailable, highly selective and potent CK2 inhibitor, with IC50 values of 1 nM against CK2α and CK2α'. It induces cell-cycle arrest and selectively induces apoptosis in cancer cells, attenuates PI3K/Akt signaling, and its antiproliferative activity correlates with CK2α catalytic subunit expression. It also prevents leukemic cells from engaging a functional UPR and decreases pro-survival ER chaperon BIP/Grp78 expression.

  • Highly selective and potent CK2 inhibitor (IC50 of 1 nM against CK2α and CK2α')
  • Induces cell-cycle arrest and selective apoptosis in cancer cells
  • Attenuates PI3K/Akt signaling and suppresses CK2-mediated PI3K/Akt/mTOR signaling
  • Exerts anti-proliferative effects in hematological tumors
  • Prevents leukemic cells from engaging a functional UPR and decreases pro-survival ER chaperon BIP/Grp78 expression

Catalog No. 50-003-58772


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.